![Arie Mayer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 529 906 $ in data 31/08/2026
Arie Mayer has been Chairman & Managing Director at Sigma-Aldrich Israel Ltd. since 2010, with employment at the firm starting in 1995.
Since 2019, Dr. Mayer has served as an Independent Director at Oramed Pharmaceuticals, Inc. Education includes a doctorate from Technion-Israel Institute of Technology and an undergraduate degree from The Hebrew University of Jerusalem.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 20/07/2026 | 105.559 ( 0,26% ) | 529 906 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ORAMED PHARMACEUTICALS INC. | Direttore/Membro del Consiglio | 05/12/2019 |
Sigma-Aldrich Israel Ltd.
 Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Amministratore Delegato | 01/01/2010 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Technion-Israel Institute of Technology
 Technion-Israel Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oramed Pharmaceuticals, Inc.
 Oramed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Sigma-Aldrich Israel Ltd.
Sigma-Aldrich Israel Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
